Januzzi, James L.

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiac pacing and defibrillation studies

Cited by 12,536

Cardiovascular and renal outcomes with empagliflozin in heart failure

Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 5,206

Empagliflozin in heart failure with a preserved ejection fraction

Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 4,874

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 3,304

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association

Bozkurt, B., Coats, A. J. S., Tsutsui, H., Abdelhamid, C. M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., et al. (2021) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 1,665

Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation

Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesAtrial Fibrillation Management and Outcomes

Cited by 1,383

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

Lala, A., Johnson, K. W., Januzzi, J. L., Russak, A. J., Paranjpe, I., Richter, F., Zhao, S., Somani, S., Van Vleck, T., Vaid, A., et al. (2020) · Journal of the American College of Cardiology

COVID-19 Clinical Research StudiesTakotsubo Cardiomyopathy and Associated Phenomena

Cited by 791

Heart Failure With Reduced Ejection Fraction: A Review

Murphy, S. P., Ibrahim, N. E., & Januzzi, J. L. (2020) · JAMA

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 769

Anemia and Mortality in Heart Failure Patients

Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology

Erythropoietin and Anemia TreatmentHeart Failure Treatment and Management

Cited by 764

Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction

Januzzi, J. L., Prescott, M. F., Butler, J., Felker, G. M., Maisel, A. S., McCague, K., Camacho, A., Piña, I. L., Rocha, R. A., Shah, A. M., et al. (2019) · JAMA

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 634

Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon

Neilan, T. G., Januzzi, J. L., Lee-Lewandrowski, E., Ton-Nu, T.-T., Yoerger, D. M., Jassal, D. S., Lewandrowski, K. B., Siegel, A. J., Marshall, J. E., Douglas, P. S., et al. (2006) · Circulation

Cardiovascular Effects of ExerciseTakotsubo Cardiomyopathy and Associated Phenomena

Cited by 519

Characterizing the young patient with aortic dissection: results from the international registry of aortic dissection (IRAD)

Januzzi, J. L., Isselbacher, E. M., Fattori, R., Cooper, J. V., Smith, D. E., Fang, J., Eagle, K. A., Mehta, R. H., Nienaber, C. A., & Pape, L. A. (2004) · Journal of the American College of Cardiology

Aortic Disease and Treatment ApproachesConnective tissue disorders research

Cited by 511

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation

GDF15 and Related BiomarkersHeart Failure Treatment and Management

Cited by 482

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M., Morris, P. B., Neumiller, J. J., et al. (2020) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 466

Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.

Huffman, J. C., Celano, C. M., Beach, S. R., Motiwala, S. R., & Januzzi, J. L. (2013) · Cardiovascular Psychiatry and Neurology

Cardiac Health and Mental HealthAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 445

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K., Brouse, S., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., et al. (2024) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiac pacing and defibrillation studies

Cited by 362

Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic

Bhatt, A. S., Moscone, A., McElrath, E. E., Varshney, A. S., Claggett, B. L., Bhatt, D. L., Januzzi, J. L., Butler, J., Adler, D. S., Solomon, S. D., et al. (2020) · Journal of the American College of Cardiology

COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies

Cited by 357

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial

Anker, S. D., Butler, J., Filippatos, G., Khan, M. S., Marx, N., Lam, C. S. P., Schnaidt, S., Ofstad, A. P., Brueckmann, M., Jamal, W., et al. (2021) · Circulation

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 352

Clinical implications of the New York Heart Association classification

Caraballo, C., Desai, N. R., Mulder, H., Alhanti, B., Wilson, F. P., Fiuzat, M., Felker, G. M., Piña, I. L., O'Connor, C. M., Lindenfeld, J., et al. (2019) · Journal of the American Heart Association

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 351

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Cefalu, W. T., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M. L., Morris, P. B., et al. (2018) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 300

Ideal Cardiovascular Health: Associations With Biomarkers and Subclinical Disease and Impact on Incidence of Cardiovascular Disease in the Framingham Offspring Study

Xanthakis, V., Enserro, D. M., Murabito, J. M., Polak, J. F., Wollert, K. C., Januzzi, J. L., Wang, T. J., Tofler, G., & Vasan, R. S. (2014) · Circulation

Cardiovascular Health and Risk FactorsCardiovascular Health and Disease Prevention

Cited by 287

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

Spertus, J. A., Birmingham, M. C., Nassif, M., Damaraju, C. V., Abbate, A., Butler, J., Lanfear, D. E., Lingvay, I., Kosiborod, M. N., & Januzzi, J. L. (2022) · Nature Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 245

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Butler, J., Filippatos, G., Jamal Siddiqi, T., Brueckmann, M., Böhm, M., Chopra, V. K., Pedro Ferreira, J., Januzzi, J. L., Kaul, S., Piña, I. L., et al. (2022) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 206

A Novel Circulating Noncoding Small RNA for the Detection of Acute Myocarditis

Blanco-Domínguez, R., Sánchez-Díaz, R., de la Fuente, H., Jiménez-Borreguero, L. J., Matesanz-Marín, A., Relaño, M., Jiménez-Alejandre, R., Linillos-Pradillo, B., Tsilingiri, K., Martín-Mariscal, M. L., et al. (2021) · New England Journal of Medicine

Viral Infections and Immunology ResearchMicroRNA in disease regulation

Cited by 196